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 Abstract
A gradual increasing interest in cosmetic procedures and the implementation of these 
practices by non-physicians have led to the development of various complications. 
Some of these complications are transient, while others require severe systemic 
treatments, and some may be life-threatening. These complications cause depression 
and isolated from society. In this article, three different reactions in the light of literature 
data due to the application of vitamins E, which are not fillers, have been presented 
and reactions of filler substances and treatment approaches are reviewed.
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Günümüzde kozmetik işlemlere ilginin artması ve bu uygulamaların hekim olmayan 
kişiler tarafından yapılmaya başlanması çeşitli komplikasyonların gelişimine neden 
olmuştur. Bu komplikasyonların bazıları geçici olmasına karşın diğerleri ağır sistemik 
tedaviler gerektirmektedir. Bazı hastalarda hayatı tehdit eden önemli semptomlar 
gelişebilmektedir. Oluşan bu komplikasyonlar hastalarda depresyona ve toplumdan 
izolasyona neden olmaktadır. Bu makalede dolgu maddesi olmayan vitamin E içeren 
ampüllerin uygulanmasına bağlı gelişen üç farklı reaksiyon sunularak literatür verileri 
ışığında dolgu maddesi reaksiyonları ve tedavi yaklaşımları derlenmiştir. 
Anahtar kelimeler: Dolgu reaksiyonları, derleme, E vitamini, sklerödema, parafinoma, 
lipogranüloma
 Öz
Introduction
Interest in cosmetic procedures is gradually 
increasing today. Filler substance injection, 
used to reduce wrinkles and eliminate age-
related volume loss, is a type of aesthetic 
application. Application of filler substances 
may lead to complications. The complication 
rate may increase if the procedure is 
conducted by inexperienced physicians 
or non-physicians (1). Our study exams 
complications which developed following 
filler injection, with potential complications 
and treatment approaches reviewed as well.
Case Reports
Case 1
A 41-year-old female patient presented 
with thickening and hardening of the skin 
on the lip and perioral region. Her medical 
history revealed that vitamin E was injected 
into her lip area as filler for lip augmentation 
three months prior by a coiffeur. Swelling, 
redness and stiffness developed in her 
lips ten days later, and then spread 
around her mouth. Oral systemic steroids 
(methylprednisolone 32 mg/day) were 
prescribed at another health center for 
the treatment of the swelling. However, 
the steroids were discontinued because 
of the onset of diabetes mellitus following 
the steroid treatment. Glucose levels 
returned to normal levels after the steroid 
therapy was discontinued. Dermatological 
examination showed non-pitting, indurated 
plaques in the lips and around the mouth 
(Figure 1a). The patient had difficulty 
with speaking and eating. Bloodwork 
revealed normal complete blood count, 
liver function tests, thyroid hormones, 
protein electrophoresis, C-reactive protein, 
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erythrocyte sedimentation rate, anti-streptolysin O and 
complement levels. Antinuclear antibody, anti-Sjögren’s 
syndrome-A/Ro, anti- Sjögren’s syndrome-B/La, anti-Sm, 
anti-Scl-70, rheumatoid factor, anti-ribonucleoprotein and 
hepatitis serology tests were negative. Histopathological 
examination showed coarsened and fenestrated collagen 
bundles in the dermis, mature adipose tissue located in 
the mid dermis and surrounding the sweat glands, and 
the presence of perivascular lymphocytic infiltration. In 
histochemical study, alcian blue pH 2.5 stain revealed 
acid mucopolysaccharide mucin material separating 
thickened collagen bundles (Figure 2). A Lupus band test 
yielded negative results with a direct immunofluorescence 
test. These clinical and histopathological findings were 
consistent with the diagnosis of scleredema, and the 
patient was administered oral methotrexate (15 mg/week) 
and colchicine 0.5 mg TID. Within a month of initiating this 
treatment, lip function improved. At the end of the third 
month of treatment, the sclerosis completely resolved 
(Figure 1b).
Case 2
A 33-year-old female patient was admitted with erythematous 
nodules on her face and thigh of six days’ duration. The patient 
had injected herself with vitamin E after attending a platelet 
rich plasma course, and developed nodular lesions 3 weeks 
after the injection. Dermatological examination revealed 
multiple erythematous firm nodules on her cheek, forehead 
and on the anterior surface of her thigh (Figure 3, 4). A punch 
biopsy was obtained from the plaques. Histopathologic 
findings were consistent with lipogranuloma. Systemic 
steroids (methylprednisolone 32 mg/d) and topical steroid 
treatment were initiated. Facial lesions resolved within one 
month and the lesions on the thigh within two months. 
Intralesional steroid injection was applied to a small number 
of remaining lesions. All lesions developed post-inflammatory 
pigmentation.
Case 3
A 51-year-old female patient was admitted with swelling, 
erythema and stiffness of her face (Figure 5, 6). Her medical 
history revealed that vitamin E and co-enzyme Q was 
injected to her lip area as filler one year prior by a coiffeur. 
Botulinum toxin injection was applied around the eyes at 
two-week intervals at a different center two months before 
her current admission. She had experienced burning, tingling 
and redness in her eyes one week after the last application, 
and symptoms did not resolve despite hot-cold applications. 
Redness, swelling and firmness developed in her face, 
especially in her cheeks. The swelling in her right cheek 
spontaneously ruptured and drained; however, the swelling 
increased again thereafter. She was hospitalized, and a punch 
biopsy obtained from the right malar region revealed foreign 
body granuloma. She was started on systemic methyl-
prednisolone (48 mg/d), ampicillin-sublactam, linezolid, and 
metronidazole treatment. Erythrocyte sedimentation rate, 
C-reactive protein levels and edema regressed with these 
treatments and she was discharged with ciprofloxacin (500 
mg bid PO), an analgesic and a tapering dose of steroids. Upon 
admittance to our clinic, bilateral malar erythema, edema 
and wood stiff subcutaneous nodules were detected on 
her physical examination. Laboratory examination revealed 
a mild leukocytosis (13.800/μL), mild neutrophilia (90.9%), 
lymphopenia (7.3%), and elevated total IgE (386 IU/mL). 
Anti-nuclear antibody was negative and C1 inhibitor level 
was normal. The results were debated at dermatopathology 
council and systemic methyl-prednisolone (0.75 mg/kg/d), 
cyclosporine (5 mg/kg/d) and azithromycin (1500 mg/m) 
treatments were started. Soft tissue magnetic resonance 
imaging revealed thickness in subcutaneous tissue 
neighboring the maxillary and mandibular regions bilaterally, 
in the left preseptal zygomatic region, and hypo-intense 
regions and contrast in T1-T2. Malar edema and firmness 
began to regress at day 15 of treatment.
Discussion
Interventional cosmetic procedures administered by physicians 
other than dermatologists and plastic surgeons, and even 
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Figure 1a. Sclerotic plaques restricting mouth movements 
in a patient with scleredema due to vitamin E injection
Figure 1b. Complete recovery of indurated plaques after 
treatment
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Figure 2. a) Histopathology shows fat tissue surrounding the sweat glands in mid dermis (arrows), b,c) thickened and 
fenestrated collagen bundles in the dermis, d) Alcian blue positive mucin structures (a, H&E x100; b and c, H&E x200; d, 
Alcian blue x200)
Figure 3. Multiple erythematous nodules on the thigh of a 
patient with lipogranuloma due to vitamin E injection
Figure 4. Multiple erythematous nodules on the face of a 
patient with lipogranuloma due to vitamin E injection
by non-physicians, lead to significant medical complications. 
For patients who are seeking to improve their appearances, 
these complications may lead to depression, suicide attempts 
and even death (2). A literature review revealed that 77.5% of 
foreign body reactions associated with cosmetic application 
developed due to illegal applications (3). We presented three 
cases with complications secondary to vitamin E injection by 
a non-physician, with two cases developing complications 
following treatment by a hairdresser, and another after the 
patient self-administered vitamin E.
Filler materials are known to cause various cutaneous 
reactions (Table 1) (4). Temporal erythema, edema and 
tenderness develop in many patients. These acute reactions 
are related to application technique rather than the injected 
substance. These local reactions develop in 93% of the 
patients who used hyaluronic acid and in 90% of the patients 
who used collagen (5). Applying ice to the affected region is 
usually beneficial if a reaction develops. Green tinted makeup 
may be used to camouflage erythema (4).
Filler injections not only lead to temporal erythema but also 
cause malar edema, which lasts for days or even months. 
Malar edema usually develops due to compression on 
lymphatic vessels as the result of the applications in the 
infraorbital region. This complication may be treated with 
hyaluronidase when hyaluronic acid filler has been utilized. 
However, treatment is quite difficult with other fillers. Cold 
compresses or manual lymphatic massage may be beneficial 
(4).
Ecchymosis due to blood extravasation may develop during 
filler injection. This reaction is usually self-limiting within 5-10 
days. Ecchymosis occurs frequently in the perioral region, the 
inferior eyelid and the nasolabial sulcus. This complication 
may be reduced through cessation of analgesics, aspirin, 
and some vitamins (vitamin E, ginseng, garlic, ginger, gingko, 
morina liver fat) 10 days before the application, by avoiding 
injections in regions with visible vessels, by using fine needles 
or blunt cannulas, and by applying the injections to the 
superficial fat layer and pre-periosteal levels (4,6). Applying 
compression with or without ice may reduce ecchymosis. 
There is no definite evidence that vitamin K and bromalin 
reduce ecchymosis. Hemoglobin-targeting vascular laser and 
light sources may be used if ecchymosis persists (4).
Acute erythema, edema and severe itching at filler site are 
signs of a type 1 allergic reaction. These acute hypersensitivity 
reactions are quite rare. Local pain, swelling and erythema 
are seen in mild reactions. A skin test is recommended prior 
to bovine collagen injections due to the high risk of reaction 
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Figure 5. Facial swelling, erythema and stiffness on face of 
patient with lipogranuloma due to vitamin E injection
Figure 6. Facial swelling, erythema and stiffness on face of 
patient with lipogranuloma due to vitamin E injection
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Table 1. Prevention and treatment methods for complications of filler material injection
Prevention Treatment
Early reactions
Erythema and edema - Ice packs,
- Topical anesthetics
- Nerve blocks
- Use blunt cannulas
- Ice bags
- Hyaluronidase for hyaluronic acid filler
- Intralesional steroids
- Laser and microdermabrasion
Ecchymosis - Avoid drugs and herbs that cause bleeding
- Avoid injection at visible vessel sites
- Use smallest gauge needle or blunt cannulas
- Use epinephrine-containing fillers
- Inject slowly
- Avoid injections at the superficial fat or preperiosteal 
layer
- Cold compresses
- Vascular lasers
Bacterial infection - Use antiseptic solution before the cosmetic application - Avoid massage
- Antibiotic
Viral infection Use antiherpetic prophylaxis before cosmetic application 
if the patient has a history of herpes virus infection
- Systemic acyclovir or valaciclovir
Urticaria, angioedema and 
anaphylaxis
- Skin test especially for animal-sourced fillers - Oral antihistamines
- Oral or intralesional steroid
- Remove the filler material
- Adrenalin (for anaphylaxis)
Tyndale effect - Avoid secondary to superficial injections - Massage
- Aspiration
- Hyaluronidase (for hyaluronic acid)
Arterial occlusion - Inject at subdermal level in periocular region - Compression
- Hyaluronidase (for hyaluronic acid)
- Topical nitroglycerin
- Hot compresses
- Oral aspirin
- Daily follow up
- Referral to cardiovascular surgeon
Late reactions
Malar edema - Avoid using viscose filler material at malar region
- Make pre-periosteal level injection at malar septum
- Cold compresses
- Manual lymphatic compression
- Hyaluronidase (for hyaluronic acid)
Fungal infection - Use antiseptic solution (alcohol or chlorhexidine) before 
the cosmetic application
- Avoid filler in immunosuppressed patients
- Antifungal treatment
Mycobacterial infection - Use antiseptic solution (alcohol or chlorhexidine) before 
the cosmetic application
- Avoid contact with tap water and ice obtained from tap 
water
- Clarithromycin
- Rifampicin
- Doxycycline
- Ciprofloxacin
Scleredema - Avoid injecting inappropriate material - Systemic steroid
- Methotrexate
- Colchicine
Foreign body reaction - Avoid permanent filler - Hyaluronidase (for hyaluronic acid)
- Intralesional steroid
- Systemic steroid
- Immunosuppressive drugs
- Surgery
Tissue necrosis - Avoid excessive filler injection
- Avoid injecting with high pressure
B cell lymphoma and 
squamous cell carcinoma
- Avoid injecting inappropriate material - Surgery
- Radiotherapy
*Reactions occurred immediately or within a few days after the procedure, **Reactions occurred in weeks or years
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(3%). For individuals with a negative skin test result, risk of 
allergic reaction drops to less than 0.5%. Allergic reaction to 
hyaluronic acid is quite rare. These reactions usually develop 
against the proteins in the filler. Most reactions regress with 
antihistamines, although adrenalin and systemic steroids may 
be required for individuals who develop angio-edema and 
anaphylaxis. Emergency kits should be available at the facilities 
where filler is administered, though these severe reactions are 
rare (4). Widespread urticarial reaction, serum reaction-like 
fever, arthralgia and distant rash are reported infrequently in 
patients who develop a foreign body reaction (7).
Nodules may develop in filler sites in the early or late reaction 
period. Painless and non-erythematous nodules, seen shortly 
after filler application, usually develop due to excessive filler 
substance injection. Hyaluronidase may be used for treatment 
if hyaluronic acid was initially used as filler. If the nodule has 
developed due to the use of the other filler materials, the 
area may be drained through a small incision. Drainage may 
not be possible if there are extensive nodules (8). For these 
cases, intralesional 5-fluoro-uracil, a radiofrequency method, 
is utilized when surgery cannot be performed (4). The risk 
of developing cutaneous nodules increases with some filler 
materials. Five millimeter or smaller nodules may develop, 
particularly after poly-L-lactic acid injection, or rarely after 
the use of other materials. Filler material should be diluted 
further (minimally 5 mL), held for 24 h or longer (preferably 
72 h) after dilution, kept at room temperature until applied, 
and applied to the subcutaneous fat layer instead of the 
dermis to eliminate these reactions (6).
Type 4 hypersensitivity reactions are another cause of nodular 
lesion development. These foreign body reactions vary 
depending on the injected filler material. While intradermal 
collagen and hyaluronic acid fillers may lead to cystic 
granulomas, subdermal silicon and acrylamide applications 
form Swiss cheese-like, honeycomb-shaped lipogranulomas 
(9). Sclerosing type granulomas develop due to subdermal 
injection of fillers like artecol (10).
A slowly developing erythema and induration is seen in 
patients who develop cystic-type foreign body reactions. 
Unlike sclerosing types of lesions, fluctuation develops in 
all cystic granulomas within 1-3 months. Induration usually 
resolves spontaneously within one year. The characteristic 
histopathological finding of cystic type foreign body reactions 
is foreign body-type giant cells, neutrophils, lymphocytes and 
macrophages surrounding the necrobiotic implant material. 
These granulomas may also be defined as collagen cells 
swimming in a sea of neutrophils (10).
Erythema is seen in patients who develop edematous 
granulomas. Usually, lymphocytes and macrophages are seen 
around the foreign material, and giant cells are rarely present. 
Intralesional steroid treatment is usually recommended for 
these cases (10).
Sarcoidosis-like or xanthomatous-type sclerosing granulomas 
develop within 6-24 months following filler injection. 
Inflammation lasts for years unless these types of granulomas 
are treated. Slowly growing erythema, swelling and firmness 
develop in the whole injection site within a couple of weeks. 
Histopathologic examination reveals increased fibroblasts 
and macrophages between microspheres. Finger-type 
extensions are seen extending into the tissue surrounding 
the infiltration. The injection material may be identified using 
a polarized microscope (10).
Filler injection may lead to pigmentation changes in the skin. 
Post-inflammatory pigmentation may develop following 
ecchymosis in particularly dark-skinned individuals. Topical 
hydroquinone and tretinoin cream can be used in addition 
to sunscreen. A white color change may be observed when 
bovine collagen is injected superficially as a filler, while 
superficial injection of hyaluronic acid leads to a blue color 
change (Tyndale effect). This color change may be treated 
with massage, aspiration or hyaluronidase (11).
Bacterial, fungal or viral infection may develop secondary 
to filler injection. These infections may be polymicrobial. 
Herpes virus infections are the most common viral infection. 
Acyclovir or valaciclovir prophylaxis should be recommended 
for the patients who have a history of recurrent herpes 
virus infection. Additionally, as herpes infections are often 
secondarily infected with bacteria, antibiotics are usually used 
in conjunction with the antiviral treatment. Infection-related 
abscesses may be seen as a solitary lesion or in multiples. 
Candida infections, which develop in immune-compromised 
patients, are often difficult to differentiate (8). Infections may 
initially be confused with local non-infectious reactions. To 
reduce infection risk, all injection sites should be cleaned with 
an antiseptic solution like alcohol and chlorhexidine prior to 
treatment. With any suspicious lesion, antibiotics should be 
recommended. Any abscess requiring draining should be 
cultured, with antibiogram results determining the antibiotic 
selected. Another factor in treating a secondary infection 
is biofilm formation. Released by some bacteria, a biofilm’s 
protective film layer can hinder the effect of antibiotics by 
serving as a protective shield. Atypical mycobacteria should 
also be eliminated in persistent infections despite two weeks 
of antibiotic treatment (12).
Filler materials may also lead to vascular complications, which 
may be local or distant to the injection site. Local reactions 
may occur from intravascular injection of the filler material, 
causing thrombosis as well as secondary to excessive 
compression. Distant vascular complications develop due to 
intravascular injection of the filler material (4).
Severe pain at the injection site is the most important sign of 
a local vascular reaction. The skin pales, and capillary filling 
time prolongs. The skin becomes livedoid spotty before 
turning cyanotic. Necrosis occurs secondary to permanent 
ischemia. Ulcers develop with the sloughing of the necrotic 
layer. Hyperbaric oxygen, systemic antibiotic treatment, 
massage, vasodilators and supportive treatments are required 
for cases with vascular complications. Hyaluronidase may be 
used if hyaluronic acid had been injected. Ocular vessels may 
become obstructed after injection of filler material into the 
vessels around the eyes (13). Corneal edema, hyphema and 
visual impairment may subsequently develop. To prevent 
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these important complications, the following points should 
be strictly followed: Vascular structures around the eye 
should be carefully considered, blunt cannulas should be 
used preferentially, epinephrine-containing local anesthetics 
should be utilized for a vasoconstrictive effect, whether the 
tip of the syringe has entered the vessel should be verified 
prior to injecting, filler material should be applied gently 
and slowly with less than 0.1 mL in each region, and hard 
compression should be avoided after the injection (14).
Intravascular injection of the filler material may lead to 
systemic complications in addition to the local effects. 
Progressive dyspnea and confusion were reported 
secondary to facial injection of hyaluronic acid-containing 
filler material. A subsequent chest tomography revealed 
a ground glass appearance, but lung biopsy results were 
consistent with a foreign body granuloma. This complication 
developed as a result of a non-thrombotic pulmonary 
embolism and was thought to be due to intravascular 
and excessive volume injection, as well as inappropriate 
massage afterwards (15).
Injection of inappropriate materials also leads to 
complications. The complications seen in our three cases 
developed due to vitamin E injection. Vitamin E injection-
related scleredema was first reported in our case although 
vitamin E injection-related lipogranuloma and paraffinoma 
development had previously been reported (1). All three 
patients required long-term steroid use to resolve their 
complications. The first patient developed steroid-related 
diabetes, so methotrexate and colchicine treatment were 
started and the scleredema lesions completely recovered 
within three months.
Lipogranulomas may develop due to the traumatic effect of 
some filler materials on endogenous lipids or from exogenous 
application of paraffin, mineral oil, vaseline, silicon, vitamin 
E and autologous fat (16). These exogenous materials may 
lead to early or late lipogranuloma formation. As seen in 
our first case, early reactions generally develop within a few 
weeks of treatment and respond well to steroids. Conversely, 
reactions to exogenous paraffin develop months or even years 
(paraffinoma) after treatment. Initially, pain and tenderness 
develop at the injection site. Depigmentation or a dark yellow 
color change is observed in the skin. Fibrosis-related induration 
and restriction in movement develops in advanced stages, 
and cutaneous necrosis and ulceration may also develop. 
Sometimes this oily material reaches the lymph nodes and 
the lungs through lymphatic and hematogenous routes, and 
death has even been reported. Histopathological examination 
of affected tissues reveals destruction in subcutaneous fat, 
with hyaline necrosis in stromal septa. Fibrotic tissue causes 
the formation of fat globules of different sizes. Endothelial cells, 
foreign body-type giant cells, macrophages and eosinophilic 
collagen surround the fatty cysts. Definite treatment of 
paraffinoma is complete excision, as B-cell lymphoma and 
squamous cell carcinoma has been reported due to long-term 
paraffin presence in the skin (17,18). However, most patients do 
not want surgery due a lack of comesis afterwards. Magnetic 
resonance imaging (MRI) may be used for exact identification 
of the surgical site (19,20). Spotty mass appearance (60%), 
nodules in fat density (100%), nodular (100%) and ring (80%) 
calcification are detected on tomography (20). Fibrous plaques 
gave iso-intensity in T1 weighted images and hypo-intensity 
in T2 weighted images, while the fluid paraffin component 
gave hypo-intensity in T1 and T2 weighted images (21). It 
was reported that hyper-intensity could be observed on an 
MRI obtained within 3 years of treatment and that hyper-
intensity could be noted more than 20 years later. Hypo-
intense areas were detected in our paraffinoma case 1.5 years 
after the initial treatment. Intralesional steroids, systemic 
corticosteroids, oral tetracycline, CO2 laser, 100% trichlor acetic 
acid and radiofrequency treatments may be used to reduce 
the inflammation (16).
Conclusion
Filler material injection is an elective procedure. These 
cosmetic procedures should be performed by dermatologists 
or plastic surgeons who can also manage potential 
complications from these procedures.
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